Global Blood Therapeutics, Inc. (GBT)

NASDAQ: GBT · IEX Real-Time Price · USD
+0.86 (2.78%)
At close: Jun 24, 2022 4:00 PM
+0.16 (0.50%)
After-hours: Jun 24, 2022 6:28 PM EDT

Total Valuation

GBT has a market cap or net worth of $2.07 billion. The enterprise value is $2.17 billion.

Market Cap 2.07B
Enterprise Value 2.17B

Important Dates

The next earnings date is Tuesday, August 2, 2022, after market close.

Estimated Earnings Date Aug 2, 2022
Ex-Dividend Date n/a

Share Statistics

GBT has 65.10 million shares outstanding. The number of shares has increased by 4.41% in one year.

Shares Outstanding 65.10M
Shares Change (YoY) +4.41%
Shares Change (QoQ) +0.52%
Owned by Insiders (%) 2.73%
Owned by Institutions (%) 114.34%
Float 52.61M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 9.81
PB Ratio 15.44
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 10.28
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.52, with a Debt / Equity ratio of 4.87.

Current Ratio 8.52
Quick Ratio 7.36
Debt / Equity 4.87
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -129.70%, which is considered low. The company has a ROIC of -44.50%.

Return on Equity (ROE) -129.70%
Return on Assets (ROA) -40.90%
Return on Capital (ROIC) -44.50%
Revenue Per Employee $461,414
Profits Per Employee -$677,427
Employee Count 457
Asset Turnover 0.28
Inventory Turnover 0.07


In the past 12 months, GBT has paid $648,000 in taxes.

Income Tax 648,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -10.28% in the last 52 weeks. The beta is 1.11, so GBT's price volatility has been higher than the market average.

Beta (1Y) 1.11
52-Week Price Change -10.28%
50-Day Moving Average 25.59
200-Day Moving Average 29.55
Average Volume (30 Days) 1,442,874

Short Selling Information

The latest short interest is 10.82 million, so 16.62% of the outstanding shares have been sold short.

Short Interest 10.82M
Short % of Shares Out 16.62%
Short % of Float 20.56%
Short Ratio (days to cover) 6.55

Income Statement

In the last 12 months, GBT had revenue of $210.87 million and -309.58 million in losses. Earnings per share was -$4.86.

Revenue 210.87M
Gross Profit 207.08M
Operating Income -289.59M
Pretax Income -308.94M
Net Income -309.58M
EBITDA -280.11M
EBIT -288.95M
Earnings Per Share (EPS) -$4.86
Full Income Statement

Balance Sheet

The company has $555.87 million in cash and $653.16 million in debt, giving a net cash position of -$97.29 million or -$1.49 per share.

Cash & Cash Equivalents 555.87M
Total Debt 653.16M
Net Cash -97.29M
Net Cash Per Share -$1.49
Book Value 134.00M
Book Value Per Share 2.06
Working Capital 596.34M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$249.41 million and capital expenditures -$2.36 million, giving a free cash flow of -$251.77 million.

Operating Cash Flow -249.41M
Capital Expenditures -2.36M
Free Cash Flow -251.77M
FCF Per Share n/a
Full Cash Flow Statement


Gross margin is 98.20%, with operating and profit margins of -137.33% and -146.82%.

Gross Margin 98.20%
Operating Margin -137.33%
Pretax Margin -146.51%
Profit Margin -146.82%
EBITDA Margin -132.84%
EBIT Margin -137.03%
FCF Margin -119.40%

Dividends & Yields

GBT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -14.96%
FCF Yield -12.17%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -4.41%
Shareholder Yield -4.41%
Dividend Details

Analyst Forecast

The average price target for GBT is $60.88, which is 91.51% higher than the current price. The consensus rating is "Buy".

Price Target $60.88
Price Target Difference 91.51%
Analyst Consensus Buy
Analyst Count 26
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a